Dipeptidyl peptidase IV inhibitors derived from a mangrove flora Rhizophora mucronata: An in silico approach

Bangladesh Journal of Pharmacology

Volumn 7, Issue 3, 2012, Pages 203-210

  Gurudeeban, Selvaraj ^a   Satyavani, Kaliyamurthi ^a   Ramanathan, Thirugnansambandam ^a   Ravikumar, Palanisamy ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b BHARATHIAR UNIVERSITY   (India)

Author keywords

Human apo DPP IV protein; Mangrove; Type 2 diabetes

Indexed keywords

ACRYLAMIDE; ARGININE; CAPRYLONE; CYSTINE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUTAMIC ACID; OLEIC ACID; PHENYLACETIC ACID; SERINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; BINDING ENERGY; COMPUTER MODEL; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; HYDROGEN BOND; MANGROVE; MOLECULAR DOCKING; NONHUMAN; RHIZOPHORA MUCRONATA;

EID: 84869193436     PISSN: 1991007X     EISSN: 19910088     Source Type: Journal    
DOI: 10.3329/bjp.v7i3.11636     Document Type: Article

References (21)

1. Abbott CA, Yu DMT, Woollatt E, Sutherland GR, McCaughan GW, Gorrell MD. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem. 2000; 67: 6140-6150.
2. Balajee R, Dhanarajan MS. Identification and comparative molecular Docking analysis of 6, 7, 8, 9-tetrahydro-2H-11-oxa-2, 4, 10-triaza-benzo[B] fluoren-1-one (RBMS-01) bounds with DPP4 for anti-hyperglycemic activities. Chem Sci Transc. 2012; 1: 279-288.
3. Bandaranayake WM. Economic, traditional and medicinal uses of mangroves. Australian Institute of Marine Science, Townsville, Australia, 1999, p 82.
4. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity: A review of ten years of herbal medicine research. Int J Diabetes Metab. 2006; 14: 1-25.
5. Borges BF, Jorge MR, Morgan CM, Da Silveria DX, Custodio O. Binge-eating disorder in Brazilian women on a weight-loss program. Obesity Res. 2002; 10: 1127-1134.
6. Breda A, Basso LA, Santos DS, De Azevedo JR. Virtual screening of drugs: Score functions, docking and drug design. Curr Comput Aided Drug Des. 2008; 4: 265-272.
7. Fredenrich A, Palle S, Canivet B. Dipeptidyl peptidase inhibitors: A new step towards normoglycemia. Open Endocrinol J. 2009; 3: 16-21.
8. Gurudeeban S, Ramanathan T. Antidiabetic effect of Citrullus colocynthis in alloxan-induced diabetic rats. Inventi Rapid: Ethnopharmacol. 2010; 1: 112.
9. Gurudeeban S, Satyavani K, Ramanathan T, Balasubramanian T. Antidiabetic effect of a black mangrove species Aegiceras corniculatum in alloxan-induced diabetic rats. J Adv Pharm Technol Res. 2012; 3: 52-56.
10. Gurudeeban S, Satyavani K, Ramanathan T. Alpha glucosi-dase inhibitory effect and enzyme kinetics of coastal medicinal plants. Bangladesh J Pharmacol. 2012; 7: 186-191.
11. Khodade P, Prabhu R, Chandra N, Raha S, Govindarajan R. Parallel implementation of AutoDock. J Applied Crystallogr. 2007; 40: 598-599.
12. Kiel S, Bruss M, Bonisch H, Gothert M. Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation. Pharmacogenetics. 2000; 10:655-666.
13. Mest HJ, Mentlein R. Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes. Diabetologia 2005; 48: 616-620.
14. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998; 19: 1639-1662.
15. Ramanathan T, Hariharan B, Ganesan K. Antidiabetic activity of a coastal mangrove leaves of Rhizophora mucronata. Int. J Plant Res: Plant Arch. 2008; 8: 931-933.
16. Rohini RM, Das AK. A comparative evaluation of an analgesic and anti-inflammatory activities of I Rhizophora mucronata bark extracts. Pharmacology Online. 2009; 1: 780-791.
17. Sakashita H, Akahoshi F, Yoshida T, Kitajima H, Hayashi Y, Ishii S, Takashina Y, Tsutsumiuchi R, Ono S. Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: indoline compounds as potent DPP-IV inhibitors. Bioorg Med Chem. 2007; 15: 641-655.
18. Sunil Kumar, Vipin Kumar, Monika Rana, Dinesh Kumar. Enzymes Inhibitors From Plants: An Alternate Approach To Treat Diabetes. Pharmaco Commun. 2012; 2: 18-33.
19. nd ed. Boca Raton, FL, CRC Press, 1981, p C-259.
20. Weber AE. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J Med Chem. 2004; 47: 4135-4141.
21. Zhang S, Kumar K, Jiang X, Wallqvist A, Reifman J. DOVIS: An implementation for high-throughput virtual screening using AutoDock. BMC Bioinform. 2008; 9: 126.